196 filings
Page 3 of 10
6-K
h4zbz hm02dv75gc1e
27 Oct 23
Form 51-102F4 Business Acquisition Report
11:48am
6-K
afqn1f6q42b6q8p
26 Oct 23
Material Change Report
11:20am
6-K
sc7hf bqekpdl9fgm6xt
26 Oct 23
Cybin Announces Grant of European Patent Protecting its Proprietary Deuterated Programs
10:38am
6-K
nms8zhw5kwu9qh
25 Oct 23
Cybin Announces Grant of Two New United States Patents Protecting its Deuterated DMT Program
11:42am
6-K
1ub rh4rdmken594tho
23 Oct 23
Cybin Completes Acquisition of Small Pharma Inc. to Create International Clinical-stage Leader in Novel Psychedelic Therapeutics
2:20pm
6-K
8dbiu0ezbqu xm1
18 Oct 23
Small Pharma Obtains Final Order Approving Arrangement
1:23pm
6-K
7azls9rb5tblrpo qyk3
13 Oct 23
Cybin Announces Results of Annual and Special Meeting of Shareholders
2:20pm
6-K
rhtw27z0j1 r33y
13 Oct 23
Report of Voting Results Section 11.3 of National Instrument 51-102
11:32am
6-K
ax229nu50erpb
6 Oct 23
Cybin to Present an Abstract and Moderate a Psychedelic Workshop at the 6th Annual Neuropsychiatric Drug Development Summit
1:41pm
6-K
qe5kb
4 Oct 23
Cybin to Present at the Jefferies Inaugural Biotech CNS/Neuro Summit
11:26am
6-K
px7jdji7
3 Oct 23
Cybin Completes Dosing in Phase 2 Study of CYB003 for the Treatment of Major Depressive Disorder
5:11pm
6-K
08r06c 4i8t3
27 Sep 23
Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder
5:25pm
6-K
ile7qpc cxy9w14
27 Sep 23
Cybin Announces Agreement with Fluence to Support Scaling of EMBARK Training for CYB003 Phase 3 Trial
4:53pm
6-K
66pf2w mw
25 Sep 23
Cybin to Participate in the Cantor Global Healthcare Conference
5:25pm
6-K
ya8ilh5 7u2
21 Sep 23
Cybin Announces Date of Annual and Special Meeting of Shareholders
5:27pm
6-K
ny1grmo0dgqbqh
21 Sep 23
Cybin Completes Enrollment in Phase 2 Study of CYB003 in Major Depressive Disorder
2:49pm
6-K
t1vlxncpz3hff5qr9
14 Sep 23
Notice of Annual and Special Meeting of Shareholders
2:58pm
6-K
fx4qa0 m8
12 Sep 23
Material Change Report
12:49pm
6-K
13w3 8mh0
5 Sep 23
Cybin Announces Grant of U.S. Patent Covering Deuterated Tryptamines
5:27pm
6-K
053i80 wl674s
29 Aug 23
Current report (foreign)
10:25am